Marshall Wace’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
17,483
+6,426
+58% +$95.5K ﹤0.01% 2788
2026
Q1
$170K Sell
11,057
-4,771
-30% -$79.4K ﹤0.01% 2817
2025
Q4
$286K Buy
+15,828
New +$272K ﹤0.01% 2467
2025
Q3
Sell
-40,710
Closed -$443K 3197
2025
Q2
$443K Sell
40,710
-30,941
-43% -$347K ﹤0.01% 2187
2025
Q1
$894K Buy
+71,651
New +$1.18M ﹤0.01% 1831
2024
Q4
Sell
-17,723
Closed -$145K 2841
2024
Q3
$145K Sell
17,723
-64,853
-79% -$440K ﹤0.01% 2332
2024
Q2
$562K Buy
+82,576
New +$565K ﹤0.01% 1917
2023
Q1
Sell
-14,587
Closed -$84.9K 2936
2022
Q4
$84.9K Buy
+14,587
New +$91.2K ﹤0.01% 2808
2020
Q2
Sell
-13,078
Closed -$114K 1802
2020
Q1
$114K Buy
+13,078
New +$200K ﹤0.01% 1292

Other funds holding MESO

Marshall Wace's MESO Position: Q2 2026 in Review

Marshall Wace increased its Mesoblast (MESO) stake by 58% in Q2 2026, buying an estimated $95.5K and bringing the position to 17,483 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #2788.

Marshall Wace first reported a position in MESO in Q1 2020 and has held it in 9 quarters since. The position peaked at $894K in Q1 2025. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • Marshall Wace held 17,483 shares of Mesoblast worth $237K as of Q2 2026.
  • Marshall Wace bought 6,426 Mesoblast shares in Q2 2026, an estimated $95.5K.
  • Mesoblast made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2788 holding.
  • Marshall Wace first reported a position in Mesoblast in Q1 2020 and has held it in 9 quarters since.
  • Marshall Wace's Mesoblast position peaked at $894K in Q1 2025.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.